{"id":5795,"date":"2022-09-14T01:42:05","date_gmt":"2022-09-14T01:42:05","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=5795"},"modified":"2023-08-29T17:55:34","modified_gmt":"2023-08-29T17:55:34","slug":"clarity-pharmaceuticals-phase-ii-trial-sar-bombesin-prostate-cancer-diagnostic","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=5795","title":{"rendered":"Clarity Pharmaceuticals \u5f00\u59cb\u4f7f\u7528 SAR-Bombesin \u4f5c\u4e3a\u524d\u5217\u817a\u764c\u8bca\u65ad\u7684 II \u671f\u8bd5\u9a8c"},"content":{"rendered":"

Clarity Pharmaceuticals (ASX: CU6) \u5df2\u5f00\u59cb\u4f7f\u7528\u5176 Copper-64 SAR-Bombesin \u4ea7\u54c1\u5728\u6210\u50cf\u626b\u63cf\u4e2d\u5bf9\u524d\u5217\u817a\u764c\u60a3\u8005\u8fdb\u884c II \u671f\u8bca\u65ad\u8bd5\u9a8c\u3002<\/p>\n

\u6839\u636e Clarity \u7684\u8bf4\u6cd5\uff0c SAR-Bombesin \u662f\u4e00\u79cd\u201c\u9ad8\u5ea6\u9776\u5411\u201d\u7684\u5e7f\u6cdb\u764c\u75c7\u653e\u5c04\u6027\u836f\u7269\u3002<\/p>\n

\u5b83\u5177\u6709\u201c\u5e7f\u6cdb\u7684\u764c\u75c7\u5e94\u7528\u201d\uff0c\u5e76\u901a\u8fc7\u9776\u5411\u80c3\u6ccc\u7d20\u91ca\u653e\u80bd\u53d7\u4f53 (GRPr) \u53d1\u6325\u4f5c\u7528\uff0c\u8be5\u53d7\u4f53\u5b58\u5728\u4e8e\u4e00\u7cfb\u5217\u764c\u7ec6\u80de\u4e2d\uff0c\u5305\u62ec\u524d\u5217\u817a\u3001\u4e73\u817a\u764c\u548c\u5375\u5de2\u6076\u6027\u80bf\u7624\u3002<\/p>\n

GRPr \u5b58\u5728\u4e8e 75-100% \u7684\u524d\u5217\u817a\u764c\u4e2d\u3002<\/p>\n

SAR-Bombesin \u4f7f\u7528 Clarity \u4e13\u6709\u7684\u77f3\u849c\u78b1 (SAR) \u6280\u672f\uff0c\u8be5\u6280\u672f\u5c06\u94dc\u540c\u4f4d\u7d20\u4fdd\u6301\u5728\u201c\u7b3c\u72b6\u7ed3\u6784\u5185\u201d\uff0c\u79f0\u4e3a\u87af\u5408\u5242\u3002<\/p>\n

Clarity \u8868\u793a\uff0c\u4e0e\u5176\u4ed6\u5e02\u552e\u87af\u5408\u5242\u4e0d\u540c\uff0c\u5176 SAR \u6280\u672f\u53ef\u9632\u6b62\u94dc\u6cc4\u6f0f\u5230\u4f53\u5185\u3002<\/p>\n

\u9664\u4e86\u4f5c\u4e3a Copper-64 \u7684\u8bca\u65ad\u5de5\u5177\u5916\uff0cCopper-67 \u8fd8\u53ef\u4ee5\u4e0e SAR-Bombesin \u914d\u5bf9\u7528\u4e8e\u9776\u5411\u6cbb\u7597\u3002<\/p>\n

\u524d\u5217\u817a\u764c\u8bd5\u9a8c<\/h2>\n

\u521a\u521a\u5f00\u59cb\u7684 II \u671f\u7814\u7a76\u4eba\u5458\u542f\u52a8\u8bd5\u9a8c (IIT) \u6b63\u5728\u8bc4\u4f30 SAR-Bombesin \u5728\u524d\u5217\u817a\u7279\u5f02\u6027\u819c\u6297\u539f (PSMA) \u9634\u6027\u524d\u5217\u817a\u764c\u60a3\u8005\u6210\u50cf\u4e2d\u7684\u5b89\u5168\u6027\u548c\u8bca\u65ad\u6f5c\u529b\u3002<\/p>\n

\u5728\u4eca\u5929\u7684\u516c\u544a\u4e2d\uff0cClarity \u900f\u9732\u5df2\u7ecf\u62db\u52df\u4e86\u7b2c\u4e00\u6279\u60a3\u8005\u5e76\u4e3a\u8bd5\u9a8c\u8fdb\u884c\u4e86\u6210\u50cf\u3002<\/p>\n

\u591a\u8fbe 30 \u540d\u60a3\u8005\u5c06\u53c2\u52a0\u8bd5\u9a8c\uff0c\u8be5\u8bd5\u9a8c\u5728 Louise Emmett \u6559\u6388\u7684\u9886\u5bfc\u4e0b\u5728\u6089\u5c3cSt Vincent\u2019s Hospital\u8fdb\u884c\u3002<\/p>\n

\u201cSAR-Bombesin \u4ea7\u54c1\u5bf9\u4e8e\u5927\u91cf\u60a3\u8005\u7fa4\u4f53\u6765\u8bf4\u662f\u4e00\u4e2a\u5f88\u6709\u5e0c\u671b\u7684\u76ee\u6807\uff0c\u8fd9\u4e9b\u60a3\u8005\u7fa4\u4f53\u7684\u9700\u6c42\u672a\u5f97\u5230\u6ee1\u8db3\uff0c\u800c\u4e14\u4ed6\u4eec\u53ef\u7528\u7684\u6cbb\u7597\u65b9\u6cd5\u5f88\u5c11\uff0c\u201dEmmett \u6559\u6388\u89e3\u91ca\u8bf4\u3002<\/p>\n

\u201c\u6211\u4eec\u5f88\u9ad8\u5174\u73b0\u5728\u53ef\u4ee5\u5728\u4e34\u5e8a\u8bd5\u9a8c\u6761\u4ef6\u4e0b\u5c06\u4ea7\u54c1\u63d0\u4f9b\u7ed9\u66f4\u591a\u7684\u60a3\u8005\u3002\u201d<\/p>\n

Emmett \u6559\u6388\u6307\u51fa\uff0cSAR-Bombesin \u5df2\u7ecf\u901a\u8fc7\u6fb3\u5927\u5229\u4e9a\u6cbb\u7597\u7528\u54c1\u7ba1\u7406\u5c40\u7279\u6b8a\u51c6\u5165\u8ba1\u5212\u4e0b\u7684\u4e00\u9879 PSMA \u7814\u7a76\u4ee5\u53ca\u4e00\u9879\u8c03\u67e5 SAR-Bombesin \u5728\u4e73\u817a\u764c\u60a3\u8005\u4e2d\u7684\u8bd5\u70b9\u8bca\u65ad\u7814\u7a76\uff0c\u663e\u793a\u51fa\u201c\u975e\u5e38\u6709\u5e0c\u671b\u7684\u6570\u636e\u201d\u3002<\/p>\n

\u5728\u76ee\u524d\u7684\u8bd5\u9a8c\u4e2d\uff0c\u5c06\u8bc4\u4f30\u4e24\u7ec4\u4e0d\u540c\u7684\u7537\u6027\u3002\u7b2c\u4e00\u7ec4\u5c06\u6d89\u53ca\u7591\u4f3c\u524d\u5217\u817a\u764c\u751f\u5316\u590d\u53d1\u4e14 PSMA \u4f4d\u7f6e\u53d1\u5c04\u65ad\u5c42\u626b\u63cf (PET) \u6210\u50cf\u626b\u63cf\u4e3a\u9634\u6027\u6216 PSMA \u8868\u8fbe\u4f4e\u7684\u60a3\u8005\u3002<\/p>\n

\u7b2c\u4e8c\u7ec4\u5c06\u5305\u62ec\u4e0d\u7b26\u5408 PSMA \u6cbb\u7597\u6761\u4ef6\u7684\u8f6c\u79fb\u6027\u53bb\u52bf\u62b5\u6297\u6027\u524d\u5217\u817a\u764c\u60a3\u8005\u3002<\/p>\n

Clarity \u6267\u884c\u4e3b\u5e2dAlan Taylor\u535a\u58eb\u5728\u8bc4\u8bba\u8fd9\u9879\u7814\u7a76\u65f6\u8bf4\uff0c\u4ed6\u76f8\u4fe1 SAR-Bombesin \u6709\u53ef\u80fd\u5728\u5927\u91cf\u60a3\u8005\u7fa4\u4f53\u4e2d\u63d0\u4f9b\u201c\u51c6\u786e\u548c\u7cbe\u786e\u7684\u764c\u75c7\u68c0\u6d4b\u548c\u6cbb\u7597\u201d\u3002<\/p>\n

\u653e\u5c04\u6027\u836f\u7269\u4e13\u5bb6\u52a0\u5165 Clarity<\/h2>\n

\u672c\u5468\u65e9\u4e9b\u65f6\u5019\uff0cClarity \u900f\u9732 Jeffrey Norenberg \u535a\u58eb\u5df2\u88ab\u4efb\u547d\u4e3a\u516c\u53f8\u7684\u9996\u5e2d\u79d1\u5b66\u5b98\u3002<\/p>\n

Norenberg \u535a\u58eb\u5728\u653e\u5c04\u6027\u836f\u7269\u9886\u57df\u62e5\u6709\u8d85\u8fc7 3 \u5e74\u7684\u7ecf\u9a8c\uff0c\u5176\u4e2d\u5305\u62ec 27 \u5e74\u7684\u836f\u5b66\u3001\u9ebb\u9189\u5b66\u548c\u91cd\u75c7\u76d1\u62a4\u533b\u5b66 (Pharmacy and Anesthesiology and Critical Care Medicine) \u540d\u8a89\u6559\u6388\u4ee5\u53caUniversity of New Mexico\u7684Health Sciences Centre\u653e\u5c04\u6027\u836f\u7269\u79d1\u5b66\u4e3b\u4efb\u3002<\/p>\n

Taylor \u535a\u58eb\u8bf4\uff0cNorenberg \u535a\u58eb\u5728 Clarity \u5f00\u53d1\u548c\u5546\u4e1a\u5316\u5176\u4e0b\u4e00\u4ee3\u653e\u5c04\u6027\u836f\u7269\u65f6\u4e3a Clarity \u5e26\u6765\u4e86\u201c\u9ad8\u5ea6\u76f8\u5173\u548c\u6709\u4ef7\u503c\u7684\u201d\u4e13\u4e1a\u77e5\u8bc6\u3002<\/p>\n

\u4e2d\u56fd\u4e13\u5229<\/h2>\n

Clarity \u8fd8\u62a5\u544a\u8bf4\uff0c\u5b83\u5df2\u5728\u4e2d\u56fd\u83b7\u5f97\u4e00\u9879\u4e13\u5229\uff0c\u6db5\u76d6\u5176 SAR-bisPSMA \u9776\u5411\u5242\u3002<\/p>\n

\u8be5\u4e13\u5229\u662f\u5728\u7f8e\u56fd\u3001\u6fb3\u5927\u5229\u4e9a\u548c\u58a8\u897f\u54e5\u4e4b\u524d\u6388\u4e88 SAR-bisPSMA \u7684\u4e13\u5229\u4e4b\u540e\u7684\uff0c\u5176\u4ed6\u4e13\u5229\u5728\u6b27\u6d32\u548c\u65e5\u672c\u6b63\u5728\u7533\u8bf7\u4e2d\u3002<\/p>\n

\u201c\u8fd9\u4e00\u91cc\u7a0b\u7891\u5ef6\u7eed\u4e86 Clarity \u5bf9\u77e5\u8bc6\u4ea7\u6743 (IP) \u4fdd\u62a4\u7684\u9ad8\u5ea6\u91cd\u89c6\uff0c\u6db5\u76d6 SAR \u6280\u672f\u5e73\u53f0\u4ee5\u53ca\u7531\u6b64\u4ea7\u751f\u7684\u6bcf\u6b3e\u65b0\u4ea7\u54c1\uff0c\u201dTaylor\u535a\u58eb\u8bf4\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

Clarity Pharmaceuticals (ASX: CU6) \u5df2\u5f00\u59cb\u4f7f\u7528\u5176 Copper-64 SAR-Bombesin \u4ea7\u54c1\u5728\u6210\u50cf\u626b\u63cf\u4e2d\u5bf9\u524d\u5217\u817a\u764c\u60a3\u8005\u8fdb\u884c II \u671f\u8bca\u65ad\u8bd5\u9a8c\u3002 \u6839\u636e Clarity \u7684\u8bf4\u6cd5\uff0c SAR-Bombesin \u662f\u4e00\u79cd\u201c\u9ad8\u5ea6\u9776\u5411\u201d\u7684\u5e7f\u6cdb\u764c\u75c7\u653e\u5c04\u6027\u836f\u7269\u3002 \u5b83\u5177\u6709\u201c\u5e7f\u6cdb\u7684\u764c\u75c7\u5e94\u7528\u201d\uff0c\u5e76\u901a\u8fc7\u9776\u5411\u80c3\u6ccc\u7d20\u91ca\u653e\u80bd\u53d7\u4f53 (GRPr) \u53d1\u6325\u4f5c\u7528\uff0c\u8be5\u53d7\u4f53\u5b58\u5728\u4e8e\u4e00\u7cfb\u5217\u764c\u7ec6\u80de\u4e2d\uff0c\u5305\u62ec\u524d\u5217\u817a\u3001\u4e73\u817a\u764c\u548c\u5375\u5de2\u6076\u6027\u80bf\u7624\u3002 GRPr \u5b58\u5728\u4e8e 75-100% \u7684\u524d\u5217\u817a\u764c\u4e2d\u3002 SAR-Bombesin \u4f7f\u7528 Clarity \u4e13\u6709\u7684\u77f3\u849c\u78b1 (SAR) \u6280\u672f\uff0c\u8be5\u6280\u672f\u5c06\u94dc\u540c\u4f4d\u7d20\u4fdd\u6301\u5728\u201c\u7b3c\u72b6\u7ed3\u6784\u5185\u201d\uff0c\u79f0\u4e3a\u87af\u5408\u5242\u3002 Clarity \u8868\u793a\uff0c\u4e0e\u5176\u4ed6\u5e02\u552e\u87af\u5408\u5242\u4e0d\u540c\uff0c\u5176 SAR \u6280\u672f\u53ef\u9632\u6b62\u94dc\u6cc4\u6f0f\u5230\u4f53\u5185\u3002 \u9664\u4e86\u4f5c\u4e3a Copper-64 \u7684\u8bca\u65ad\u5de5\u5177\u5916\uff0cCopper-67 \u8fd8\u53ef\u4ee5\u4e0e SAR-Bombesin \u914d\u5bf9\u7528\u4e8e\u9776\u5411\u6cbb\u7597\u3002 \u524d\u5217\u817a\u764c\u8bd5\u9a8c \u521a\u521a\u5f00\u59cb\u7684 II \u671f\u7814\u7a76\u4eba\u5458\u542f\u52a8\u8bd5\u9a8c (IIT) \u6b63\u5728\u8bc4\u4f30 SAR-Bombesin \u5728\u524d\u5217\u817a\u7279\u5f02\u6027\u819c\u6297\u539f (PSMA) \u9634\u6027\u524d\u5217\u817a\u764c\u60a3\u8005\u6210\u50cf\u4e2d\u7684\u5b89\u5168\u6027\u548c\u8bca\u65ad\u6f5c\u529b\u3002 \u5728\u4eca\u5929\u7684\u516c\u544a\u4e2d\uff0cClarity \u900f\u9732\u5df2\u7ecf\u62db\u52df\u4e86\u7b2c\u4e00\u6279\u60a3\u8005\u5e76\u4e3a\u8bd5\u9a8c\u8fdb\u884c\u4e86\u6210\u50cf\u3002 \u591a\u8fbe 30 \u540d\u60a3\u8005\u5c06\u53c2\u52a0\u8bd5\u9a8c\uff0c\u8be5\u8bd5\u9a8c\u5728 Louise Emmett… Continue reading Clarity Pharmaceuticals \u5f00\u59cb\u4f7f\u7528 SAR-Bombesin \u4f5c\u4e3a\u524d\u5217\u817a\u764c\u8bca\u65ad\u7684 II \u671f\u8bd5\u9a8c<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":19272,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[1231],"yoast_head":"\nClarity Pharmaceuticals \u5f00\u59cb\u4f7f\u7528 SAR-Bombesin \u4f5c\u4e3a\u524d\u5217\u817a\u764c\u8bca\u65ad\u7684 II \u671f\u8bd5\u9a8c<\/title>\n<meta name=\"description\" content=\"Clarity Pharmaceuticals (ASX: CU6) \u5df2\u5f00\u59cb\u4f7f\u7528\u5176 Copper-64 SAR-Bombesin \u4ea7\u54c1\u5728\u6210\u50cf\u626b\u63cf\u4e2d\u5bf9\u524d\u5217\u817a\u764c\u60a3\u8005\u8fdb\u884c II \u671f\u8bca\u65ad\u8bd5\u9a8c\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clarity Pharmaceuticals \u5f00\u59cb\u4f7f\u7528 SAR-Bombesin \u4f5c\u4e3a\u524d\u5217\u817a\u764c\u8bca\u65ad\u7684 II \u671f\u8bd5\u9a8c\" \/>\n<meta property=\"og:description\" content=\"Clarity Pharmaceuticals (ASX: CU6) \u5df2\u5f00\u59cb\u4f7f\u7528\u5176 Copper-64 SAR-Bombesin \u4ea7\u54c1\u5728\u6210\u50cf\u626b\u63cf\u4e2d\u5bf9\u524d\u5217\u817a\u764c\u60a3\u8005\u8fdb\u884c II \u671f\u8bca\u65ad\u8bd5\u9a8c\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/clarity-pharmaceuticals-phase-ii-trial-sar-bombesin-prostate-cancer-diagnostic\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-14T01:42:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:55:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Clarity-Pharmaceuticals-ASX-CU6-phase-II-trial-SAR-Bombesin-prostate-cancer-diagnostic-imaging-scans.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/clarity-pharmaceuticals-phase-ii-trial-sar-bombesin-prostate-cancer-diagnostic\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/clarity-pharmaceuticals-phase-ii-trial-sar-bombesin-prostate-cancer-diagnostic\/\",\"name\":\"Clarity Pharmaceuticals \u5f00\u59cb\u4f7f\u7528 SAR-Bombesin \u4f5c\u4e3a\u524d\u5217\u817a\u764c\u8bca\u65ad\u7684 II \u671f\u8bd5\u9a8c\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2022-09-14T01:42:05+00:00\",\"dateModified\":\"2023-08-29T17:55:34+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"Clarity Pharmaceuticals (ASX: CU6) \u5df2\u5f00\u59cb\u4f7f\u7528\u5176 Copper-64 SAR-Bombesin \u4ea7\u54c1\u5728\u6210\u50cf\u626b\u63cf\u4e2d\u5bf9\u524d\u5217\u817a\u764c\u60a3\u8005\u8fdb\u884c II \u671f\u8bca\u65ad\u8bd5\u9a8c\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/clarity-pharmaceuticals-phase-ii-trial-sar-bombesin-prostate-cancer-diagnostic\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/clarity-pharmaceuticals-phase-ii-trial-sar-bombesin-prostate-cancer-diagnostic\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/clarity-pharmaceuticals-phase-ii-trial-sar-bombesin-prostate-cancer-diagnostic\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clarity Pharmaceuticals \u5f00\u59cb\u4f7f\u7528 SAR-Bombesin \u4f5c\u4e3a\u524d\u5217\u817a\u764c\u8bca\u65ad\u7684 II \u671f\u8bd5\u9a8c\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Clarity Pharmaceuticals \u5f00\u59cb\u4f7f\u7528 SAR-Bombesin \u4f5c\u4e3a\u524d\u5217\u817a\u764c\u8bca\u65ad\u7684 II \u671f\u8bd5\u9a8c","description":"Clarity Pharmaceuticals (ASX: CU6) \u5df2\u5f00\u59cb\u4f7f\u7528\u5176 Copper-64 SAR-Bombesin \u4ea7\u54c1\u5728\u6210\u50cf\u626b\u63cf\u4e2d\u5bf9\u524d\u5217\u817a\u764c\u60a3\u8005\u8fdb\u884c II \u671f\u8bca\u65ad\u8bd5\u9a8c\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Clarity Pharmaceuticals \u5f00\u59cb\u4f7f\u7528 SAR-Bombesin \u4f5c\u4e3a\u524d\u5217\u817a\u764c\u8bca\u65ad\u7684 II \u671f\u8bd5\u9a8c","og_description":"Clarity Pharmaceuticals (ASX: CU6) \u5df2\u5f00\u59cb\u4f7f\u7528\u5176 Copper-64 SAR-Bombesin \u4ea7\u54c1\u5728\u6210\u50cf\u626b\u63cf\u4e2d\u5bf9\u524d\u5217\u817a\u764c\u60a3\u8005\u8fdb\u884c II \u671f\u8bca\u65ad\u8bd5\u9a8c\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/clarity-pharmaceuticals-phase-ii-trial-sar-bombesin-prostate-cancer-diagnostic\/","og_site_name":"smallcapsCN","article_published_time":"2022-09-14T01:42:05+00:00","article_modified_time":"2023-08-29T17:55:34+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Clarity-Pharmaceuticals-ASX-CU6-phase-II-trial-SAR-Bombesin-prostate-cancer-diagnostic-imaging-scans.jpg","type":"image\/jpeg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/clarity-pharmaceuticals-phase-ii-trial-sar-bombesin-prostate-cancer-diagnostic\/","url":"https:\/\/smallcapscn.x5view.co\/clarity-pharmaceuticals-phase-ii-trial-sar-bombesin-prostate-cancer-diagnostic\/","name":"Clarity Pharmaceuticals \u5f00\u59cb\u4f7f\u7528 SAR-Bombesin \u4f5c\u4e3a\u524d\u5217\u817a\u764c\u8bca\u65ad\u7684 II \u671f\u8bd5\u9a8c","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2022-09-14T01:42:05+00:00","dateModified":"2023-08-29T17:55:34+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"Clarity Pharmaceuticals (ASX: CU6) \u5df2\u5f00\u59cb\u4f7f\u7528\u5176 Copper-64 SAR-Bombesin \u4ea7\u54c1\u5728\u6210\u50cf\u626b\u63cf\u4e2d\u5bf9\u524d\u5217\u817a\u764c\u60a3\u8005\u8fdb\u884c II \u671f\u8bca\u65ad\u8bd5\u9a8c\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/clarity-pharmaceuticals-phase-ii-trial-sar-bombesin-prostate-cancer-diagnostic\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/clarity-pharmaceuticals-phase-ii-trial-sar-bombesin-prostate-cancer-diagnostic\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/clarity-pharmaceuticals-phase-ii-trial-sar-bombesin-prostate-cancer-diagnostic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Clarity Pharmaceuticals \u5f00\u59cb\u4f7f\u7528 SAR-Bombesin \u4f5c\u4e3a\u524d\u5217\u817a\u764c\u8bca\u65ad\u7684 II \u671f\u8bd5\u9a8c"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5795"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5795"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5795\/revisions"}],"predecessor-version":[{"id":15674,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5795\/revisions\/15674"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/19272"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5795"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5795"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5795"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}